Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from PRTN3 drives immunosuppression in KRAS-mutant lung adenocarcinoma through proteolytic inactivation of CXCL9. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21654
10.3322/caac.21654 · External reference
10.1038/nrc3775
10.1038/nrc3775 · External reference
10.1056/nejmoa1200694
10.1056/nejmoa1200694 · External reference
10.1056/nejmoa1200690
10.1056/nejmoa1200690 · External reference
10.1158/2159-8290.cd-18-0099
10.1158/2159-8290.cd-18-0099 · External reference
10.1016/j.cell.2017.01.017
10.1016/j.cell.2017.01.017 · External reference
10.1158/2159-8290.cd-13-0985
10.1158/2159-8290.cd-13-0985 · External reference
10.1038/nrc3245
10.1038/nrc3245 · External reference
10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p
10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · External reference
Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors
10.1007/s10555-019-09807-3 · 2019 · External reference
10.1074/jbc.270.45.27348
10.1074/jbc.270.45.27348 · External reference
10.1016/j.immuni.2012.08.016
10.1016/j.immuni.2012.08.016 · External reference
10.1016/j.immuni.2012.11.012
10.1016/j.immuni.2012.11.012 · External reference
10.1016/j.immuni.2015.02.009
10.1016/j.immuni.2015.02.009 · External reference
10.1016/j.immuni.2019.04.010
10.1016/j.immuni.2019.04.010 · External reference
10.1172/jci113816
10.1172/jci113816 · External reference
Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener’s granulomatosis
10.1182/blood.v82.4.1221.1221 · 1993 · External reference
10.1186/ar410
10.1186/ar410 · External reference
Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties
10.1016/s0021-9258(18)92854-1 · 1991 · External reference
10.1038/nri1841
10.1038/nri1841 · External reference
10.1016/0014-5793(94)00952-x
10.1016/0014-5793(94)00952-x · External reference
10.1016/j.canlet.2018.02.034
10.1016/j.canlet.2018.02.034 · External reference
10.1016/j.canlet.2025.217584
10.1016/j.canlet.2025.217584 · External reference
10.4049/jimmunol.165.6.3366
10.4049/jimmunol.165.6.3366 · External reference
10.1046/j.1365-2184.2000.00188.x
10.1046/j.1365-2184.2000.00188.x · External reference
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
10.1186/bcr2753 · 2010 · External reference
Inflammatory Proteins HMGA2 and PRTN3 as Drivers of Vulvar Squamous Cell Carcinoma Progression
10.3390/cancers13010027 · 2020 · External reference
A large‐scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma
10.1002/jcp.29162 · 2020 · External reference
10.1074/jbc.271.6.2972
10.1074/jbc.271.6.2972 · External reference
10.1016/j.cell.2017.11.013
10.1016/j.cell.2017.11.013 · External reference
10.1111/j.0105-2896.2010.00908.x
10.1111/j.0105-2896.2010.00908.x · External reference
10.1038/ni.3201
10.1038/ni.3201 · External reference
10.1074/jbc.m115.638395
10.1074/jbc.m115.638395 · External reference
10.1074/jbc.m800266200
10.1074/jbc.m800266200 · External reference
10.1007/s10540-006-9025-9
10.1007/s10540-006-9025-9 · External reference
10.1016/j.biocel.2007.11.008
10.1016/j.biocel.2007.11.008 · External reference
10.1016/j.ccell.2020.12.012
10.1016/j.ccell.2020.12.012 · External reference
Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32/PRTN3 expression
10.1111/cas.15787 · 2023 · External reference
10.1038/nature13385
10.1038/nature13385 · External reference
10.1200/jco.2012.43.0454
10.1200/jco.2012.43.0454 · External reference
10.1158/0008-5472.can-15-1439
10.1158/0008-5472.can-15-1439 · External reference
10.1038/nrc969
10.1038/nrc969 · External reference
10.1182/blood-2017-11-742577
10.1182/blood-2017-11-742577 · External reference
10.1126/science.aac9935
10.1126/science.aac9935 · External reference
10.1016/j.immuni.2018.06.006
10.1016/j.immuni.2018.06.006 · External reference
10.1016/j.ctrv.2017.11.007
10.1016/j.ctrv.2017.11.007 · External reference
10.1038/sj.gt.3302756
10.1038/sj.gt.3302756 · External reference
10.3892/ol.2017.5994
10.3892/ol.2017.5994 · External reference
10.1016/j.bbrc.2003.09.098
10.1016/j.bbrc.2003.09.098 · External reference
10.1056/nejmoa1108735
10.1056/nejmoa1108735 · External reference
Research on the process and molecular mechanism of inhibiting serous ovarian cancer by PRTN3 and its inhibitor Sivelestat
10.1186/s13048-025-01808-x · 2025 · External reference
10.1101/gad.943001
10.1101/gad.943001 · External reference
TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness
10.1038/s41392-019-0098-x · 2019 · External reference
10.7150/thno.45280
10.7150/thno.45280 · External reference
10.7150/thno.51000
10.7150/thno.51000 · External reference
Design, synthesis and biological assessment of novel CDK4 inhibitor with potent anticancer activity
10.1016/j.bioorg.2021.104717 · 2021 · External reference
10.1038/nmeth.3337
10.1038/nmeth.3337 · External reference
